460 related articles for article (PubMed ID: 21784529)
21. Acute safety of beclomethasone dipropionate in a new CFC-free propellant system in asthmatic patients.
Ayres JG; Simmons JL; Stampone P
Respir Med; 1999 Jan; 93(1):27-32. PubMed ID: 10464845
[TBL] [Abstract][Full Text] [Related]
22. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC; Migounov VA
Respir Care; 2003 Nov; 48(11):1025-32. PubMed ID: 14585114
[TBL] [Abstract][Full Text] [Related]
23. Systemic activity of inhaled beclomethasone dipropionate: a double-blind comparison of volume spacers.
Wolthers OD; Sergio F
Acta Paediatr; 2012 Feb; 101(2):159-63. PubMed ID: 21790779
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma.
Aubier M; Wettenger R; Gans SJ
Respir Med; 2001 Mar; 95(3):212-20. PubMed ID: 11266239
[TBL] [Abstract][Full Text] [Related]
25. Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma.
Milanowski J; Qualtrough J; Perrin VL
Respir Med; 1999 Apr; 93(4):245-51. PubMed ID: 10464888
[TBL] [Abstract][Full Text] [Related]
26. Switch to non-CFC inhaled corticosteroids: a comparative efficacy study of HFA-BDP and CFC-BDP metered-dose inhalers.
Demedts M; Cohen R; Hawkinson R
Int J Clin Pract; 1999; 53(5):331-8. PubMed ID: 10695095
[TBL] [Abstract][Full Text] [Related]
27. A new HFA-134a propellant in the administration of inhaled BDP via the Jet spacer: controlled clinical trial vs the conventional CFC.
Vondra V; Sladek K; Kotasová J; Terl M; Rossetti A; Cantini L
Respir Med; 2002 Oct; 96(10):784-9. PubMed ID: 12412977
[TBL] [Abstract][Full Text] [Related]
28. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers.
Leach CL; Davidson PJ; Hasselquist BE; Boudreau RJ
Chest; 2002 Aug; 122(2):510-6. PubMed ID: 12171824
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of HFA-BDP for adult patients with bronchial asthma: randomized crossover study with fluticasone.
Horiguchi T; Hayashi N; Ohira D; Torigoe H; Ito T; Hirose M; Sasaki Y; Shiga M; Miyazaki J; Kondo R; Tachikawa S
J Asthma; 2006 Sep; 43(7):509-12. PubMed ID: 16939990
[TBL] [Abstract][Full Text] [Related]
30. Extra-fine particles improve lung delivery of inhaled steroids in infants: a study in an upper airway model.
Janssens HM; De Jongste JC; Hop WC; Tiddens HA
Chest; 2003 Jun; 123(6):2083-8. PubMed ID: 12796192
[TBL] [Abstract][Full Text] [Related]
31. Both bronchial and alveolar exhaled nitric oxide are reduced with extrafine beclomethasone dipropionate in asthma.
Nicolini G; Chetta A; Simonazzi A; Tzani P; Aiello M; Olivieri D
Allergy Asthma Proc; 2010; 31(5):85-90. PubMed ID: 20929599
[TBL] [Abstract][Full Text] [Related]
32. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
Ayres JG; Millar AB; Sykes AP
Respir Med; 2000 Jun; 94 Suppl B():S42-50. PubMed ID: 10919685
[TBL] [Abstract][Full Text] [Related]
33. Equivalent efficacy and safety of a new HFA-134a formulation of BDP compared with the conventional CFC in adult asthmatics.
Anderson PB; Langley SJ; Mooney P; Jones J; Addlestone R; Rossetti A; Cantini L
J Investig Allergol Clin Immunol; 2002; 12(2):107-13. PubMed ID: 12371526
[TBL] [Abstract][Full Text] [Related]
34. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone.
Leach CL; Davidson PJ; Boudreau RJ
Eur Respir J; 1998 Dec; 12(6):1346-53. PubMed ID: 9877489
[TBL] [Abstract][Full Text] [Related]
35. Effect of changing the fine particle mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics.
Seale JP; Harrison LI
Respir Med; 1998 Jun; 92 Suppl A():9-15. PubMed ID: 9850358
[TBL] [Abstract][Full Text] [Related]
36. Comparison of hydrofluoroalkane-beclomethasone dipropionate Autohaler with budesonide Turbuhaler in asthma control.
Worth H; Muir JF; Pieters WR
Respiration; 2001; 68(5):517-26. PubMed ID: 11694816
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of inhaled ciclesonide compared with chlorofluorocarbon beclomethasone dipropionate in adults with moderate to severe persistent asthma.
Adachi M; Ishihara K; Inoue H; Kudo K; Takahashi K; Morita Y; Masuda K; Sakai T; Kato R; Miyamoto T
Respirology; 2007 Jul; 12(4):573-80. PubMed ID: 17587425
[TBL] [Abstract][Full Text] [Related]
38. The cost effectiveness of chlorofluorocarbon-free beclomethasone dipropionate in the treatment of chronic asthma: a cost model based on a 1-year pragmatic, randomised clinical study.
Price D; Haughney J; Duerden M; Nicholls C; Moseley C
Pharmacoeconomics; 2002; 20(10):653-64. PubMed ID: 12162754
[TBL] [Abstract][Full Text] [Related]
39. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.
Busse WW; Brazinsky S; Jacobson K; Stricker W; Schmitt K; Vanden Burgt J; Donnell D; Hannon S; Colice GL
J Allergy Clin Immunol; 1999 Dec; 104(6):1215-22. PubMed ID: 10589004
[TBL] [Abstract][Full Text] [Related]
40. [A multicenter, open-label, randomized comparison of suppressive effects on asthmatic inflammation of lower airways and improved effects on health-related QOL between HFA-BDP and fluticasone propionate].
Ohbayashi H; Adachi M; Ichinose M; Ohta K; Kokubu F; Sano Y; Tamura G; Tohda Y; Hirata K; Yasuba H
Arerugi; 2007 Jun; 56(6):577-86. PubMed ID: 17615501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
